| Revenue | 8,029.92a | 6,321.56a |
| Cost of sales | -6,581.95a | -5,103.82a |
| Gross profit | 1,447.97a | 1,217.74a |
| Research and development expenses | -765.28a | -707.28a |
| Selling and marketing expenses | -39.85a | -36.16a |
| General and administration expenses | -580.04a | -482.26a |
| Impairment losses on financial assets, net | -0.11a | -1.26a |
| Other operating income | 411.21a | 364.45a |
| Profit from operations | 473.9a | 357.75a |
| Interest income | 546.06a | 736.59a |
| Finance costs | -297.11a | -209.42a |
| Foreign exchange gain | 11.26a | 11.16a |
| Other gains, net | 96.84a | 262.59a |
| Share of profit of associates and a joint venture | 28.61a | 28.79a |
| Profit before tax | 859.56a | 1,187.45a |
| Income tax expense | -129.57a | -62.51a |
| Profit for the year | 729.99a | 1,124.94a |
| Profit for the year attributable to | — | — |
| Owners of the Company | 492.75a | 902.53a |
| Non-controlling interests | 237.25a | 222.41a |